Literature DB >> 9092947

Intracellular acidification induces apoptosis by stimulating ICE-like protease activity.

I J Furlong1, R Ascaso, A Lopez Rivas, M K Collins.   

Abstract

ICE-like protease activation and DNA fragmentation are preceded by a decrease in intracellular pH (pHi) during apoptosis in the IL-3 dependent cell line BAF3. Acidification occurs after 7 hours in cells deprived of IL-3 and after 4 hours when cells are treated with etoposide, close to the time of detection of ICE-like protease activity. Increasing extracellular pH reduces ICE-like protease activation and DNA fragmentation. Bcl-2 over-expression both delays acidification and inhibits ICE-like protease activation. Generation of a rapid intracellular pH decrease, using the ionophore nigericin, induces ICE-like protease activation and apoptosis. ZVAD, a cell permeable inhibitor of ICE-like proteases, does not affect acidification but inhibits apoptosis induced by IL-3 removal or nigericin treatment. These data suggest that intracellular acidification triggers apoptosis by directly or indirectly activating ICE-like proteases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092947     DOI: 10.1242/jcs.110.5.653

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  26 in total

1.  Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH.

Authors:  A R Khaled; K Kim; R Hofmeister; K Muegge; S K Durum
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Bax-induced apoptotic cell death.

Authors:  J Pawlowski; A S Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide.

Authors:  S Roy; C I Bayly; Y Gareau; V M Houtzager; S Kargman; S L Keen; K Rowland; I M Seiden; N A Thornberry; D W Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

4.  Conformational modification of serpins transforms leukocyte elastase inhibitor into an endonuclease involved in apoptosis.

Authors:  Laura Padron-Barthe; Chloé Leprêtre; Elisabeth Martin; Marie-France Counis; Alicia Torriglia
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

5.  Alkaliptosis: a new weapon for cancer therapy.

Authors:  Jiao Liu; Feimei Kuang; Rui Kang; Daolin Tang
Journal:  Cancer Gene Ther       Date:  2019-08-30       Impact factor: 5.987

6.  A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas.

Authors:  R Marches; E S Vitetta; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 7.  Self-incompatibility in Papaver pollen: programmed cell death in an acidic environment.

Authors:  Ludi Wang; Zongcheng Lin; Marina Triviño; Moritz K Nowack; Vernonica E Franklin-Tong; Maurice Bosch
Journal:  J Exp Bot       Date:  2019-04-12       Impact factor: 6.992

8.  The effects of different concentrations of acetylsalicylic acid on proliferation and viability of lymphocytes in cell culture.

Authors:  Tanja Dujić; Adlija Causević; Maja Malenica
Journal:  Bosn J Basic Med Sci       Date:  2008-08       Impact factor: 3.363

9.  Acidic pH promotes oligomerization and membrane insertion of the BclXL apoptotic repressor.

Authors:  Vikas Bhat; Dmitry Kurouski; Max B Olenick; Caleb B McDonald; David C Mikles; Brian J Deegan; Kenneth L Seldeen; Igor K Lednev; Amjad Farooq
Journal:  Arch Biochem Biophys       Date:  2012-08-30       Impact factor: 4.013

10.  An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

Authors:  Salvador Harguindey; Gorka Orive; Ramón Cacabelos; Enrique Meléndez Hevia; Ramón Díaz de Otazu; Jose Luis Arranz; Eduardo Anitua
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.